Friday, June 14, 2024
Home Health & Fitness India’s indigenous vaccine Covaxin from Bharat Biotech cleared for phase III trials

India’s indigenous vaccine Covaxin from Bharat Biotech cleared for phase III trials

by News Monks
A+A-
Reset

In a huge boost to India’s indigenous vaccine plan, Bharat Biotech has been given clearance for phase three trials in India. Covaxin’s third phase trials will start in the first week of November.
Under the Phase 3 trial, the vaccine will be administered to 22 thousand people across 19 places. The government aims to vaccinate 20 to 25 crore people between January and July next year.
The government has also sought a list of all those who will be given the vaccine. Initially, the vaccine will be given on a priority basis. It is to be noted that India manufacturers around 60% of vaccine supply worldwide.

You may also like

Leave a Comment

Introducing NewsMonks, your premier source for comprehensive and concise news coverage. Dive into the world of business news, alongside a diverse range of other current topics. Stay informed, stay ahead with NewsMonks. Your go-to destination for news that matters.

 

Contact : +91 6351857103 (WA Only)

Email: newsmonnks@gmail.com 

 

Live Traffic

Edtior's Picks

All Rights Reserved by NewsMonks @2023.,
Powered by MediaHives.com